# Pediatric Oncology Clinical Research Training Program

> **NIH NIH K12** · BAYLOR COLLEGE OF MEDICINE · 2020 · $923,163

## Abstract

ABSTRACT
This proposal constitutes the renewal application of the Pediatric Oncology Clinical Research Training
Program (POCRTP), developed by Baylor College of Medicine's (BCM) Texas Children's Cancer Center.
This training program is predicated on the premise that the development of pediatric oncologists who are
highly trained in clinical research is essential for ongoing advancements in the treatment of childhood
cancer. This renewal application highlights the impressive academic accomplishments and progress of the
individual Scholars trained during the last fourteen years, with an emphasis on results from the last funding
period. Scholars must have completed a three-year pediatric hematology-oncology fellowship training
program and be either board-eligible or - certified in that subspecialty to be eligible. The program is
structured to provide a formal, comprehensive, multidisciplinary clinical research educational program.
They receive a three-year combination of didactic and mentored training experience in the design,
implementation, conduct, and analysis of clinical research trials. The program emphasizes training in
therapeutic research that occurs in team research settings in which basic and clinical scientists interact to
expedite the translation of basic research discoveries into patient-oriented therapeutic cancer research.
The program includes participation in a core didactic course in clinical investigation and trial design,
provided through BCM's Clinical Scientist Training Program, and an in-depth clinical research training
experience focused in one of five specialized research Pathways, chosen by each Scholar, and tailored
to meet the individual Scholar's long-term career goals. The POCRTP Pathways include: Clinical
Pharmacology and Developmental Therapeutics, Neuro-oncology, Cell and Gene Therapy, Hematologic
Malignancies, and Solid Tumors. An elective rotation at the National Cancer Institute's Cancer Therapy
Evaluation Program is a feature of this program. All Scholars receive comprehensive mentorship from a
laboratory research (basic) mentor and from a clinical research mentor. They receive in-depth
instruction in clinical trial design, statistical analysis, research ethics, regulatory requirements and
guidelines, scientific writing, grantsmanship, and leadership. In addition, Scholars design and conduct
clinical trials in their respective Pathways. This POCRTP has had significant representation from
underrepresented minorities. The overall experience to date indicates that Scholars who complete this
program are exceptionally well-trained in clinical research, highly successful in obtaining NIH funding, and
well- positioned to become future leaders in pediatric oncology clinical research. Of the 21 Scholars who
have completed this program, 6 are Associate Professors, 12 are Assistant Professors, one is an attending
physician at a children's hospital, and two have clinical research positions in the pharmaceutical industry.

## Key facts

- **NIH application ID:** 9949368
- **Project number:** 5K12CA090433-19
- **Recipient organization:** BAYLOR COLLEGE OF MEDICINE
- **Principal Investigator:** SUSAN M. BLANEY
- **Activity code:** K12 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $923,163
- **Award type:** 5
- **Project period:** 2002-07-01 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9949368

## Citation

> US National Institutes of Health, RePORTER application 9949368, Pediatric Oncology Clinical Research Training Program (5K12CA090433-19). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/9949368. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*